MCID: OVR060
MIFTS: 40

Ovary Epithelial Cancer

Categories: Cancer diseases, Endocrine diseases, Reproductive diseases

Aliases & Classifications for Ovary Epithelial Cancer

MalaCards integrated aliases for Ovary Epithelial Cancer:

Name: Ovary Epithelial Cancer 12 15
Ovarian Surface Epithelial-Stromal Tumor 12
Epithelial Tumor of Ovary 72

Classifications:



External Ids:

Disease Ontology 12 DOID:2152
NCIt 50 C4381
UMLS 72 C0341823

Summaries for Ovary Epithelial Cancer

Disease Ontology : 12 An ovarian cancer that is derives from ovarian surface epithelium.

MalaCards based summary : Ovary Epithelial Cancer, also known as ovarian surface epithelial-stromal tumor, is related to krukenberg carcinoma and ovarian mucinous neoplasm. An important gene associated with Ovary Epithelial Cancer is TP53 (Tumor Protein P53), and among its related pathways/superpathways are TGF-Beta Pathway and Response to elevated platelet cytosolic Ca2+. The drugs Tranexamic Acid and Hemostatics have been mentioned in the context of this disorder. Affiliated tissues include ovary, liver and brain, and related phenotypes are Decreased viability in esophageal squamous lineage and Decreased sensitivity to paclitaxel

Related Diseases for Ovary Epithelial Cancer

Diseases related to Ovary Epithelial Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 237)
# Related Disease Score Top Affiliating Genes
1 krukenberg carcinoma 32.8 KRT7 HNF1B
2 ovarian mucinous neoplasm 32.8 WT1 KRT7 CEACAM5
3 malignant ovarian surface epithelial-stromal neoplasm 29.4 WT1 VEGFA TP53 PIK3CA PAX8 KRT7
4 ovarian cancer 29.0 VEGFA TP53 PTEN PIK3CA KRT7 KRAS
5 malignant epithelial tumor of ovary 11.4
6 ovarian squamous cell neoplasm 11.3
7 ovarian endometrial cancer 11.3
8 ovarian papillary neoplasm 11.3
9 hereditary site-specific ovarian cancer syndrome 11.0 BRCA2 BRCA1
10 cancerophobia 10.8 BRCA2 BRCA1
11 tuberculous salpingitis 10.8 ERBB2 BRCA2 BRCA1
12 nosophobia 10.8 BRCA2 BRCA1
13 papillary serous adenocarcinoma 10.8 TP53 KRT7 BRCA1
14 fallopian tube adenocarcinoma 10.8 ERBB2 BRCA2 BRCA1
15 nephrogenic adenoma of urinary bladder 10.8 PAX8 KRT7
16 mutagen sensitivity 10.8 TP53 BRCA2 BRCA1
17 gastric papillary adenocarcinoma 10.8 TP53 ERBB2
18 cerebellar angioblastoma 10.8 WT1 TP53
19 cervical adenocarcinoma 10.8 TP53 KRT7 ERBB2
20 hidradenocarcinoma 10.8 TP53 KRT7 ERBB2
21 granulosa cell tumor of the ovary 10.8 TP53 KRT7 ERBB2
22 adult hepatocellular carcinoma 10.8 TP53 PIK3CA
23 bilateral breast cancer 10.8 ERBB2 BRCA2 BRCA1
24 breast squamous cell carcinoma 10.8 TP53 PIK3CA ERBB2
25 acinar cell carcinoma 10.8 TP53 KRT7 BRCA2
26 epithelial-myoepithelial carcinoma 10.8 TP53 KRT7 HRAS
27 rare adenocarcinoma of the breast 10.8 TP53 PIK3CA KRAS
28 lobular neoplasia 10.8 ERBB2 CDH1 BRCA1
29 pseudomyxoma peritonei 10.8 TP53 KRT7 KRAS
30 thyroid hurthle cell adenoma 10.7 PTEN PIK3CA
31 breast cystic hypersecretory carcinoma 10.7 ERBB2 CDH1
32 appendix disease 10.7 KRT7 KRAS HRAS
33 liver angiosarcoma 10.7 TP53 KRAS HRAS
34 endocervical adenocarcinoma 10.7 TP53 PAX8 KRT7
35 colloid carcinoma of the pancreas 10.7 KRAS HRAS BRCA2
36 barrett's adenocarcinoma 10.7 TP53 KRAS ERBB2
37 anal canal adenocarcinoma 10.7 KRT7 KRAS HRAS
38 ovarian clear cell adenocarcinoma 10.7 PIK3CA HNF1B ARID1A
39 sweat gland cancer 10.7 TP53 KRT7 ERBB2
40 anal gland adenocarcinoma 10.7 KRT7 CEACAM5
41 oropharynx cancer 10.7 TP53 KRT7 CDH1
42 mucinous lung adenocarcinoma 10.7 KRAS HRAS ERBB2
43 cutaneous mucoepidermoid carcinoma 10.7 KRT7 CEACAM5
44 glycogen-rich clear cell breast carcinoma 10.7 TP53 KRT7 BRCA2 BRCA1
45 sarcomatoid renal cell carcinoma 10.7 TP53 PAX8 CDH1
46 duodenum cancer 10.7 KRT7 KRAS HRAS
47 dysgerminoma of ovary 10.7 WT1 BRCA2 BRCA1
48 intracranial chondrosarcoma 10.7 TP53 CEACAM5
49 skin squamous cell carcinoma 10.7 TP53 PIK3CA HRAS
50 lung adenoid cystic carcinoma 10.7 PIK3CA KRAS HRAS

Graphical network of the top 20 diseases related to Ovary Epithelial Cancer:



Diseases related to Ovary Epithelial Cancer

Symptoms & Phenotypes for Ovary Epithelial Cancer

GenomeRNAi Phenotypes related to Ovary Epithelial Cancer according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased viability in esophageal squamous lineage GR00235-A 9.44 ARID1A BRCA1 BRCA2 CDH1 ERBB2 HNF1B
2 Decreased sensitivity to paclitaxel GR00112-A-0 8.96 PTEN WT1

MGI Mouse Phenotypes related to Ovary Epithelial Cancer:

46 (show all 21)
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.44 ACSBG1 ARID1A BRCA1 BRCA2 CDH1 ERBB2
2 endocrine/exocrine gland MP:0005379 10.43 ACSBG1 ARID1A BRCA1 BRCA2 CDH1 ERBB2
3 cellular MP:0005384 10.4 ARID1A BRCA1 BRCA2 CDH1 ERBB2 KRAS
4 growth/size/body region MP:0005378 10.39 ARID1A BRCA1 BRCA2 CDH1 ERBB2 HNF1B
5 cardiovascular system MP:0005385 10.38 ARID1A BRCA1 CDH1 ERBB2 HRAS KRAS
6 embryo MP:0005380 10.38 ARID1A BRCA1 BRCA2 CDH1 ERBB2 HNF1B
7 mortality/aging MP:0010768 10.32 ARID1A BRCA1 BRCA2 CDH1 ERBB2 HNF1B
8 immune system MP:0005387 10.26 ARID1A BRCA1 BRCA2 CDH1 HNF1B KRAS
9 digestive/alimentary MP:0005381 10.23 BRCA1 BRCA2 CDH1 ERBB2 HRAS KRAS
10 integument MP:0010771 10.21 BRCA1 BRCA2 CDH1 ERBB2 HRAS KRAS
11 neoplasm MP:0002006 10.21 ARID1A BRCA1 BRCA2 CDH1 ERBB2 HRAS
12 muscle MP:0005369 10.16 ARID1A BRCA1 ERBB2 HNF1B KRAS PIK3CA
13 nervous system MP:0003631 10.14 ARID1A BRCA1 BRCA2 ERBB2 HRAS KRAS
14 craniofacial MP:0005382 10.13 ARID1A ERBB2 HRAS KRAS PAX8 TP53
15 limbs/digits/tail MP:0005371 10.1 BRCA1 BRCA2 ERBB2 KRAS PAX8 PTEN
16 normal MP:0002873 10.1 ARID1A BRCA1 BRCA2 CDH1 ERBB2 HRAS
17 no phenotypic analysis MP:0003012 10.07 ARID1A CDH1 ESS2 HRAS KRAS PAX8
18 reproductive system MP:0005389 9.97 ACSBG1 ARID1A BRCA1 BRCA2 CDH1 ERBB2
19 renal/urinary system MP:0005367 9.96 BRCA1 HNF1B HRAS KRAS KRT7 PAX8
20 respiratory system MP:0005388 9.56 BRCA1 ERBB2 HRAS KRAS PTEN TP53
21 skeleton MP:0005390 9.36 ARID1A BRCA1 BRCA2 ERBB2 HRAS KRAS

Drugs & Therapeutics for Ovary Epithelial Cancer

Drugs for Ovary Epithelial Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 80)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Tranexamic Acid Approved Phase 4 1197-18-8 5526
2 Hemostatics Phase 4
3 Coagulants Phase 4
4 Antifibrinolytic Agents Phase 4
5 Pharmaceutical Solutions Phase 4
6
Parathyroid hormone Approved, Investigational Phase 2 9002-64-6
7
Ritonavir Approved, Investigational Phase 2 155213-67-5 392622
8
Indinavir Approved Phase 2 150378-17-9 5362440
9
Fondaparinux Approved, Investigational Phase 2 104993-28-4
10
Gefitinib Approved, Investigational Phase 2 184475-35-2 123631
11
Docetaxel Approved, Investigational Phase 1, Phase 2 114977-28-5 148124
12
Lenograstim Approved, Investigational Phase 2 135968-09-1
13
Ifosfamide Approved Phase 2 3778-73-2 3690
14
Amifostine Approved, Investigational Phase 2 20537-88-6 2141
15
Etoposide Approved Phase 2 33419-42-0 36462
16
Mechlorethamine Approved, Investigational Phase 2 51-75-2 4033
17
Carboplatin Approved Phase 2 41575-94-4 10339178 498142 38904
18
Cyclophosphamide Approved, Investigational Phase 1, Phase 2 50-18-0, 6055-19-2 2907
19
Melphalan Approved Phase 1, Phase 2 148-82-3 460612 4053
20
Serine Approved, Nutraceutical Phase 2 56-45-1 5951
21
Oblimersen Experimental, Investigational Phase 1, Phase 2 190977-41-4
22 Cytochrome P-450 CYP3A Inhibitors Phase 2
23 Cytochrome P-450 Enzyme Inhibitors Phase 2
24 Anti-Retroviral Agents Phase 2
25 Anti-HIV Agents Phase 2
26 Fibrinolytic Agents Phase 2
27 Antithrombin III Phase 2
28 HIV Protease Inhibitors Phase 2
29
protease inhibitors Phase 2
30 Antithrombins Phase 2
31 Serine Proteinase Inhibitors Phase 2
32 Factor Xa Inhibitors Phase 2
33 Anticoagulants Phase 2
34 PENTA Phase 2
35 Imatinib Mesylate Phase 2 220127-57-1 123596
36 Protein Kinase Inhibitors Phase 2
37 Cola Phase 1, Phase 2
38 Immunologic Factors Phase 2
39 Adjuvants, Immunologic Phase 2
40 Immunosuppressive Agents Phase 2
41 Antineoplastic Agents, Phytogenic Phase 2
42 Alkylating Agents Phase 2
43 Protective Agents Phase 2
44 Radiation-Protective Agents Phase 2
45 Topoisomerase Inhibitors Phase 2
46
Isophosphamide mustard Phase 2 0
47 Etoposide phosphate Phase 2
48 Antineoplastic Agents, Alkylating Phase 2
49 Antirheumatic Agents Phase 1, Phase 2
50 Androgens Phase 1, Phase 2

Interventional clinical trials:

(show all 19)
# Name Status NCT ID Phase Drugs
1 Tranexamic Acid in Surgery of Advanced Ovarian Cancer - a Prospective Randomized Double Blind Placebo Controlled Study Completed NCT00740116 Phase 4 Tranexamic acid;0.9% NaCl solution
2 Radiation Therapy in Combination With Indinavir / Ritonavir (Crixivan / Norvir) for the Treatment of Brain Metastases: a Randomized Phase II Study Unknown status NCT00637637 Phase 2 indinavir sulfate;ritonavir
3 Women's Cancer Center Protocol #45: Prolonged Venous Thromboembolism Prophylaxis With Fondaparinux in Gynecologic Oncology Patients: An Open Label Phase II Trial Completed NCT00381888 Phase 2 fondaparinux sodium
4 Phase II Clinical Trial With Proteomic Profiling Of Imatinib Mesylate (Gleevec; STI571), A PDGFR And C-Kit Inhibitor, In Patients With Refractory Or Relapsed Epithelial Ovarian Cancer, Fallopian Tube And Primary Peritoneal Cancer Completed NCT00039585 Phase 2 imatinib mesylate
5 Phase II Pilot Study of Clinical Activity and Proteomic Pathway Profiling of the EGFR Inhibitor, ZD1839 (Iressa; Gefitinib), in Patients With Epithelial Ovarian Cancer or Cervical Cancer Completed NCT00049556 Phase 2 gefitinib
6 High Dose Ifosfamide, Carboplatin and Etoposide With Amifostine Chemoprotection Completed NCT00003657 Phase 2 Amifostine;Carboplatin;Etoposide;Ifosfamide
7 Phase I/II Study of Escalating Dose Melphalan With Autologous Pluripotent Hematopoietic Stem Cell Support and Amifostine Cytoprotection in Cancer Patients Completed NCT00003425 Phase 1, Phase 2 amifostine trihydrate;cyclophosphamide;melphalan
8 A Phase I/IIA Dose-Escalating Trial of BCL-2 Antisense (G3139) Treatment for Patients With Androgen-Independent Prostate Cancer or Other Advanced Solid Tumor Malignancies Completed NCT00003103 Phase 1, Phase 2 docetaxel
9 Phase I Study of LMB-9, a Recombinant Disulfide Stabilized Anti-Lewis Y Immunotoxin Admistered by Continuous Infusion Completed NCT00005858 Phase 1
10 Phase I Study of Oral Capecitabine (Xeloda) as a Radiation Enhancer in Locally Unresectable, Residual, or Recurrent Colorectal Cancer Localized in the Pelvis Completed NCT00003704 Phase 1 capecitabine
11 Phase I Study Of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion X 10 Days Completed NCT00006981 Phase 1
12 A Phase I Scientific Exploratory Study of Epothilone B Analog in Patients With Solid Tumors and Gynecological Malignancies Completed NCT00005807 Phase 1 BMS-247550
13 A Dose-Escalation Trial Of The Combination Of Docetaxel, Gemcitabine And Filgrastim (NEUPOGEN) For The Treatment Of Patients With Advanced Solid Tumors Completed NCT00014456 Phase 1 docetaxel;gemcitabine hydrochloride
14 A Phase I Study of NX 211 in Combination With Cisplatin Given as an IV Infusion Days 1, 2, and 3 Every 3 Weeks in Patients With Solid Tumors Completed NCT00006036 Phase 1 cisplatin;lurtotecan liposome
15 A Phase I Trial of 17-N-Allylamino-17-Demethoxy Geldanamycin (17-AAG, NSC #330507) Daily X 5 in Patients With Advanced Cancer Therapeutic Protocol Completed NCT00004065 Phase 1 tanespimycin
16 PHASE I STUDY OF TAXOTERE IN PATIENTS WITH ADVANCED MALIGNANCIES AND VARYING DEGREES OF LIVER DYSFUNCTION Completed NCT00002901 Phase 1 docetaxel
17 Phase I Clinical Trial of Oral Suberoylanilide Hydroxamic Acid - SAHA (MSK390) in Patients With Advanced Solid Tumors and Hematologic Malignancies Completed NCT00045006 Phase 1 vorinostat
18 A Study to Determine the Ability of Folate Conjugates to Target Folate Receptors in Ovarian Cancer Tumors Completed NCT00003763
19 Improving Employment Among Gynecologic Cancer Survivors Completed NCT00383279

Search NIH Clinical Center for Ovary Epithelial Cancer

Genetic Tests for Ovary Epithelial Cancer

Anatomical Context for Ovary Epithelial Cancer

MalaCards organs/tissues related to Ovary Epithelial Cancer:

41
Ovary, Liver, Brain, Prostate

Publications for Ovary Epithelial Cancer

Articles related to Ovary Epithelial Cancer:

# Title Authors PMID Year
1
Ovarian neoplasms composed of small round cells: a review. 38
15505529 2004

Variations for Ovary Epithelial Cancer

Expression for Ovary Epithelial Cancer

Search GEO for disease gene expression data for Ovary Epithelial Cancer.

Pathways for Ovary Epithelial Cancer

Pathways related to Ovary Epithelial Cancer according to GeneCards Suite gene sharing:

(show top 50) (show all 78)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.56 VEGFA TP53 PIK3CA KRAS HRAS HNF1B
2
Show member pathways
13.36 VEGFA TP53 SERPINA3 PIK3CA KRAS HRAS
3
Show member pathways
13 VEGFA TP53 PTEN PIK3CA KRAS HRAS
4
Show member pathways
13 VEGFA TP53 PTEN PIK3CA KRAS HRAS
5
Show member pathways
12.99 VEGFA TP53 PTEN PIK3CA KRAS HRAS
6
Show member pathways
12.93 VEGFA PTEN PIK3CA KRAS HRAS ERBB2
7
Show member pathways
12.92 VEGFA PTEN PIK3CA KRAS HRAS ERBB2
8 12.8 VEGFA TP53 KRAS HRAS ERBB2
9
Show member pathways
12.77 VEGFA PIK3CA KRAS HRAS CDH1
10
Show member pathways
12.77 VEGFA TP53 PTEN PIK3CA PAX8 KRAS
11
Show member pathways
12.74 TP53 PTEN PIK3CA KRAS HRAS ERBB2
12
Show member pathways
12.72 TP53 PTEN PIK3CA KRAS HRAS ERBB2
13
Show member pathways
12.71 VEGFA PTEN PIK3CA KRAS HRAS
14 12.68 VEGFA TP53 PTEN PIK3CA PAX8 KRAS
15
Show member pathways
12.62 TP53 PIK3CA KRAS HRAS ERBB2
16
Show member pathways
12.62 VEGFA TP53 PIK3CA KRAS HRAS ERBB2
17
Show member pathways
12.61 VEGFA PTEN PIK3CA KRAS HRAS
18 12.55 VEGFA TP53 PTEN PIK3CA KRAS HRAS
19
Show member pathways
12.53 TP53 PTEN PIK3CA KRAS HRAS ERBB2
20
Show member pathways
12.51 PTEN PIK3CA KRAS HRAS ERBB2
21
Show member pathways
12.46 TP53 PIK3CA KRAS HRAS ERBB2
22
Show member pathways
12.45 VEGFA TP53 PTEN PIK3CA KRAS HRAS
23
Show member pathways
12.44 PTEN PIK3CA KRAS HRAS
24
Show member pathways
12.43 TP53 PTEN PIK3CA HRAS
25
Show member pathways
12.43 PIK3CA KRAS HRAS ERBB2 CDH1
26
Show member pathways
12.42 VEGFA PIK3CA KRAS HRAS BRCA1
27 12.39 TP53 PIK3CA KRAS HRAS
28
Show member pathways
12.36 PTEN PIK3CA KRAS HRAS
29
Show member pathways
12.33 PIK3CA KRAS HRAS ERBB2
30 12.33 TP53 PIK3CA KRAS HRAS
31
Show member pathways
12.32 TP53 PTEN PIK3CA KRAS HRAS ERBB2
32 12.3 VEGFA TP53 PIK3CA KRAS HRAS ERBB2
33
Show member pathways
12.29 VEGFA TP53 KRAS HRAS
34
Show member pathways
12.27 PIK3CA KRAS HRAS CEACAM5
35
Show member pathways
12.27 VEGFA PTEN KRAS HRAS
36
Show member pathways
12.24 TP53 PTEN PIK3CA KRAS HRAS ERBB2
37 12.22 VEGFA TP53 KRAS CDH1
38 12.22 PTEN KRAS HRAS ERBB2
39 12.21 TP53 PTEN PIK3CA KRAS HRAS
40
Show member pathways
12.2 TP53 PIK3CA KRAS HRAS
41
Show member pathways
12.18 PTEN PIK3CA KRAS HRAS ERBB2
42
Show member pathways
12.17 TP53 PIK3CA KRAS HRAS
43 12.16 VEGFA TP53 PTEN KRAS CDH1 BRCA2
44
Show member pathways
12.14 PTEN PIK3CA HRAS ERBB2
45 12.13 TP53 PTEN PIK3CA KRAS HRAS ERBB2
46
Show member pathways
12.12 PIK3CA KRAS HRAS CDH1 BRCA1
47
Show member pathways
12.11 PTEN PIK3CA KRAS HRAS
48 12.1 PTEN PIK3CA KRAS HRAS
49 12.04 TP53 PTEN PIK3CA KRAS HRAS
50 12.03 TP53 PIK3CA KRAS HRAS

GO Terms for Ovary Epithelial Cancer

Biological processes related to Ovary Epithelial Cancer according to GeneCards Suite gene sharing:

(show all 23)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of protein phosphorylation GO:0001934 9.85 VEGFA KRAS HRAS ERBB2
2 negative regulation of apoptotic process GO:0043066 9.8 WT1 VEGFA TP53 PTEN HNF1B CEACAM5
3 liver development GO:0001889 9.79 PIK3CA KRAS HNF1B
4 Ras protein signal transduction GO:0007265 9.77 TP53 KRAS HRAS
5 positive regulation of epithelial cell proliferation GO:0050679 9.76 VEGFA HRAS ERBB2
6 kidney development GO:0001822 9.71 WT1 VEGFA PAX8 HNF1B
7 cell proliferation GO:0008283 9.7 TP53 PTEN BRCA2
8 cellular response to gonadotropin stimulus GO:0071371 9.59 WT1 PAX8
9 response to isolation stress GO:0035900 9.57 KRAS HRAS
10 mesonephric tubule development GO:0072164 9.56 PAX8 HNF1B
11 positive regulation of MAP kinase activity GO:0043406 9.56 VEGFA KRAS HRAS ERBB2
12 positive regulation of transcription, DNA-templated GO:0045893 9.56 WT1 TP53 PAX8 HNF1B CDH1 BRCA2
13 pronephros development GO:0048793 9.54 PAX8 HNF1B
14 cell aging GO:0007569 9.54 TP53 HRAS BRCA2
15 metanephric S-shaped body morphogenesis GO:0072284 9.51 WT1 PAX8
16 metanephric epithelium development GO:0072207 9.49 WT1 PAX8
17 cellular response to indole-3-methanol GO:0071681 9.48 CDH1 BRCA1
18 chordate embryonic development GO:0043009 9.46 BRCA2 BRCA1
19 negative regulation of mesenchymal cell apoptotic process involved in metanephros development GO:1900212 9.43 PAX8 HNF1B
20 DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator GO:0006978 9.33 TP53 BRCA2 BRCA1
21 positive regulation of gene expression GO:0010628 9.32 WT1 VEGFA TP53 PTEN MIR509-1 KRAS
22 positive regulation of transcription by RNA polymerase II GO:0045944 10.12 WT1 VEGFA TP53 PAX8 HRAS HNF1B
23 nervous system development GO:0007399 10 VEGFA PTEN ESS2 ERBB2 ARID1A

Molecular functions related to Ovary Epithelial Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 transcription regulatory region DNA binding GO:0044212 9.35 WT1 TP53 PAX8 HNF1B BRCA1
2 identical protein binding GO:0042802 9.23 VEGFA TP53 PTEN ERBB2 CEACAM5 CDH1
3 protein binding GO:0005515 10.09 WT1 VEGFA TP53 SERPINA3 PTEN PIK3CA

Sources for Ovary Epithelial Cancer

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....